These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16007524)

  • 41. Clinical hepatotoxicity associated with antifungal agents.
    Kyriakidis I; Tragiannidis A; Munchen S; Groll AH
    Expert Opin Drug Saf; 2017 Feb; 16(2):149-165. PubMed ID: 27927037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
    N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety analysis of liposomal amphotericin B in adult patients: anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia.
    Shigemi A; Matsumoto K; Ikawa K; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
    Int J Antimicrob Agents; 2011 Nov; 38(5):417-20. PubMed ID: 21885259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperkalemia associated with rapid infusion of conventional and lipid complex formulations of amphotericin B.
    Barcia JP
    Pharmacotherapy; 1998; 18(4):874-6. PubMed ID: 9692667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe and common side-effects of amphotericin B lipid complex (Abelcet).
    Ringdén O; Jønsson V; Hansen M; Tollemar J; Jacobsen N
    Bone Marrow Transplant; 1998 Oct; 22(7):733-4. PubMed ID: 9818706
    [No Abstract]   [Full Text] [Related]  

  • 48. Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation.
    Monforte V; Ussetti P; Gavaldà J; Bravo C; Laporta R; Len O; García-Gallo CL; Tenorio L; Solé J; Román A
    J Heart Lung Transplant; 2010 May; 29(5):523-30. PubMed ID: 20061165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
    Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
    Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of liposomal amphotericin B prophylaxis after liver transplantation compared with fluconazole for high-risk patients. impact on infections and mortality within one year.
    Perrella A; Esposito C; Pisaniello D; D'Alessio L; Perrella O; Marcos A; Cuomo O
    Transplant Proc; 2012 Sep; 44(7):1977-81. PubMed ID: 22974886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Amphotericin B deoxycholate prescription and adverse events in a Chilean university hospital].
    Quinteros A R; Fica C A; Abusada A N; Muñoz C L; Novoa M C; Gallardo A C
    Rev Chilena Infectol; 2010 Feb; 27(1):25-33. PubMed ID: 20140311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amphotericin B lipid complex (ABLC)-associated hypertension: case report and review.
    Rowles DM; Fraser SL
    Clin Infect Dis; 1999 Dec; 29(6):1564-5. PubMed ID: 10585814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amphotericin B-deoxycholate overdose due to administration error in pediatric patients.
    Groeneveld S; Verweij PE; Hek LV; Bökkerink JP; Warris A
    Med Mycol; 2008 Mar; 46(2):185-7. PubMed ID: 18324499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antifungal therapy and outcomes in infants with invasive Candida infections.
    Ascher SB; Smith PB; Watt K; Benjamin DK; Cohen-Wolkowiez M; Clark RH; Benjamin DK; Moran C
    Pediatr Infect Dis J; 2012 May; 31(5):439-43. PubMed ID: 22189522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversible dilated cardiomyopathy related to amphotericin B therapy.
    Danaher PJ; Cao MK; Anstead GM; Dolan MJ; DeWitt CC
    J Antimicrob Chemother; 2004 Jan; 53(1):115-7. PubMed ID: 14657095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retrospective evaluation of amphotericin B deoxycholate toxicity in a single centre series of haematopoietic stem cell transplantation recipients.
    Annaloro C; Olivares C; Usardi P; Onida F; Della Volpe A; Tagliaferri E; Deliliers GL
    J Antimicrob Chemother; 2009 Mar; 63(3):625-6. PubMed ID: 19158110
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study.
    Falci DR; da Rosa FB; Pasqualotto AC
    Mycoses; 2015 Feb; 58(2):104-12. PubMed ID: 25590436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concentrated intravitreal amphotericin B in fungal endophthalmitis.
    Payne JF; Keenum DG; Sternberg P; Thliveris A; Kala A; Olsen TW
    Arch Ophthalmol; 2010 Dec; 128(12):1546-50. PubMed ID: 21149777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of liposomal amphotericin B in bone marrow transplant.
    Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
    J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of renal safety in amphotericin B lipid complex-treated patients.
    Alexander BD; Wingard JR
    Clin Infect Dis; 2005 May; 40 Suppl 6():S414-21. PubMed ID: 15809928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.